Mental health · New York
Mental health studies in New York
117 studies have at least one recruiting site in New York. Mental health research includes studies of depression, anxiety, PTSD, bipolar disorder, schizophrenia and ADHD, testing medicines, devices and talk therapies.
117 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of Cannabidiol and Neuroimaging on Stress
Icahn School of Medicine at Mount Sinai
- Location
- New York, NY
- Eligibility basics
- Ages 18–25
- RecruitingHealthy volunteersPhase 1
MDMA-Assisted Therapy for Mental Healthcare Providers
Rachel Yehuda
- Location
- New York, NY
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Anxiety During Abstinence in AUD
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 21–55
- RecruitingHealthy volunteers
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
Ponce Medical School Foundation, Inc.
- Location
- Commack, NY + 6 other US sites
- Eligibility basics
- Ages 21–100
- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- New York, NY + 50 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Singula Phase 0.1 Primary Care Pilot
Singula Health, Inc.
- Location
- Mount Kisco, NY
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Sleep More, Stress Less: 90-Day Trial of Neuralli Mood
Efforia, Inc
- Location
- New York, NY
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Cracking Consciousness Study With Monroe & Neuphoria (Cohort 2&3)
Efforia, Inc
- Location
- New York, NY
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
MindTension
- Location
- New York, NY
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Bristol-Myers Squibb
- Location
- Staten Island, NY + 18 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
COMPASS Pathways
- Location
- New York, NY + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- Glen Oaks, NY + 19 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With…
LivaNova
- Location
- Amherst, NY + 49 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Jamaica, NY + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Jamaica, NY + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
ACP-204 in Adults With Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc.
- Location
- Syracuse, NY + 34 other US sites
- Eligibility basics
- Ages 55–95
- RecruitingPhase 4
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alpha Cognition, Inc
- Location
- Albany, NY + 21 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- Woodmere, NY + 56 other US sites
- Eligibility basics
- Ages 55–90
- Recruiting
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Abbott Medical Devices
- Location
- New York, NY + 24 other US sites
- Eligibility basics
- Ages 22–70
- RecruitingPhase 3
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Cybin IRL Limited
- Location
- New York, NY + 27 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
MapLight Therapeutics
- Location
- Cedarhurst, NY + 41 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Draig Therapeutics Ltd
- Location
- New York, NY + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Alto Neuroscience
- Location
- Amherst, NY + 38 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Axsome Therapeutics, Inc.
- Location
- Brooklyn, NY + 35 other US sites
- Eligibility basics
- Ages 18–65
Who these studies look for
Studies usually require a confirmed diagnosis and stable circumstances, and they monitor safety closely. If you are in crisis, contact a crisis line or emergency services rather than a study.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.
Questions
Will joining affect my current treatment?
Some studies require changes to medicines, which the study team manages; others add to your usual care. Talk to your own clinician before making any change.